Contributor Page
Foley Hoag LLP
 
By Seth Jaffe
Late last month, Federal Judge Rodney Sippel ruled that EPA could obtain injunctive relief against Ameren Missouri in the long-running NSR enforcement case concerning Ameren's Rush Island Plant.
By Christian Springer
If our readers have been paying attention to the news, one thing is apparent: drug pricing is trending. As we've written on here before, the Department of Health and Human Services (HHS)
By Erica Harrington
The Governor applauded such efforts as a key step in the development of this new market.
By August T. Horvath
On March 5, Food and Drug Administration Commissioner Scott Gottlieb resigned after 22 months at the helm of the agency.
By David Kluft, Julia Huston
On March 4, 2019, the United States Supreme Court held that, with certain exceptions, a copyright owner must obtain a copyright registration certificate from the Copyright Office before filing a copyright infringement suit.
By David Kluft
On March 4, 2019, the United States Supreme Court held that, with certain exceptions, a copyright owner must obtain a copyright registration certificate ...
By Jesse Alderman
There is no business quite like cannabis, and very few that need constant attention to regulatory compliance in every aspect of operations.
By Foley Hoag LLP
Our client, Sunrun, the nation's leading home solar, battery storage and energy services company, won an historic bid to deliver home solar and batteries as a capacity resource in ISO-NE's
By Carol Holahan
Earlier this month, Federal Energy Regulatory Commission Chairman Neil Chaterjee testified before the U.S. Senate Committee on Energy and Natural Resources on issues related to cybersecurity in the energy industry.
By Meredith Haviland, Robert Sawyer
As a reminder, fund managers relying on the exemption from registration with the U.S. Commodity Futures Trading Commission (the "CFTC") set forth in Rule 4.13(a)(3), commonly referred to as the "de minimis exemption," must affirm their claim of exemption by this Friday, March 1, 2019.
By Foley Hoag LLP
CBD, or cannabidiol, is one of the two most prominent molecules found in the cannabis plant. But unlike the other more well-known cannabinoid, THC (tetrahydrocannabinol), CBD doesn't have any psychoactive properties.
By Stacie S. Aarestad
In apparent recognition of the popularity of "testing the waters" by EGCs before proceeding with an IPO, the Securities and Exchange Commission recently voted to propose an expansion of this accommodation to all companies.
By Michael Rosen, Christopher Feudo, Christian Garcia
The SJC affirmed the lower court's decision.
By Thomas Barker
One of the most common misperceptions of the American health care system is that if an elderly individual ...
By Seth Jaffe
On Tuesday, the Massachusetts Appeals Court denied a regulatory takings claim brought by a plaintiff whose development plans for her property in Falmouth were denied by the Falmouth Conservation
Contributor's Topics
More...